Roots Analysis

Roots Analysis provide business research and consulting in the pharmaceutical industry. Focussed on providing an informed and impartial view on key issues facing the industry, our research is primarily driven by an in-depth analysis covering the following parameters:

•Technology evolution
•Research and development
•Existing market landscape
•Future Commercial potential
•Regulatory concerns
•Regional growth drivers
•Risks and opportunities

Roots Analysis
 

List of reports from Roots Analysis

Sustained Release Ocular Drug Delivery Systems Market, 2014-2024
4/8/2014 | published by: Roots Analysis
... Several barriers have to be overcome for successful ocular drug delivery. For example, dilution of a drug by tears, clearance of a drug by the lymphatic system of conjunctiva, drug permeation issues with respect to ...  |  read more...
$1,899.00
3D Bioprinting Market, 2014-2030
3/5/2014 | published by: Roots Analysis
... benefitted from multiple advancements in this field, resulting in improved and more efficient processes worldwide. A quick look at www.3dprintingchannel.com suggests that 3D printing has multi-faceted dimensions; the technology has recently been used in varied ...  |  read more...
$1,899.00
Bispecific Antibodies: Clinical Trial Tracker
2/13/2014 | published by: Roots Analysis
... different epitopes concurrently. Various technology platforms have been used for bsAbs production over the years. These platforms are based on the concepts of chemical crosslinking, hybrid hybridomas, with the latest being recombinant techniques. Different binding ...  |  read more...
$799.00
Antibody Drug Conjugates: Contract Manufacturing Market, 2014-2024
2/5/2014 | published by: Roots Analysis
... antibody. However, the practical challenge of manufacturing such complex and highly toxic molecules is huge. The multi-component aspect of ADCs deems it necessary to have both biologic and high-potency facilities. Despite the fact that this ...  |  read more...
$1,899.00
Oral Proteins and Peptides Market, 2014-2024
11/21/2013 | published by: Roots Analysis
... made some progress in other routes of delivery such as transdermal, intranasal, inhalation and oral administration. Amongst the various modes of administration, oral delivery is the most preferred route. Although very convenient, there are many ...  |  read more...
$1,699.00
Antibody Drug Conjugates: Clinical Trial Tracker
11/6/2013 | published by: Roots Analysis
... of an antibody with a toxic drug / chemotherapy drug, these conjugates are believed to be more efficient and effective in the treatment of a disease. The ADC market is still in its infancy. The ...  |  read more...
$799.00
Bolus Injectors Market, 2014-2024
11/1/2013 | published by: Roots Analysis
... auto-injectors, the market has come a long way. Taking the concept of self-injectors to a new stratum, ‘Bolus Injectors’ have surfaced recently. Also known as non-insulin patch pumps, these devices not only offer a range ...  |  read more...
$1,699.00
Bispecific Antibody Therapeutics Market, 2013-2023
9/24/2013 | published by: Roots Analysis
... anti-CD3 antibody, Orthoclone Okt3, in 1986. A bispecific antibody is a second generation immunotherapy, an upgraded version of monoclonal antibody improved in structure and functionality. The conjugated artificial antibodies are formed by physically putting together ...  |  read more...
$1,699.00
Fc Protein and Glycoengineered Antibodies Market, 2013 – 2023
9/4/2013 | published by: Roots Analysis
... is to develop antibodies with improved efficacy. Research done in the last decade to develop engineered antibodies has yielded a rich knowledge base on how to develop and market these next generation antibodies. These therapeutic ...  |  read more...
$1,699.00
Prefilled Syringes Market, 2013 - 2023
7/1/2013 | published by: Roots Analysis
... patients to self-administer medication several times a week. The rising demand for prefilled syringes is driving the manufacturers to introduce improvements in technology related to the material of prefilled syringes, and lubrication technology to reduce ...  |  read more...
$1,699.00
Companion Diagnostics Market, 2012-2023
6/6/2013 | published by: Roots Analysis
... potential abnormalities and tailoring the treatment so as to make it as individualised as the disease itself. Targeted drugs have been fast to overshadow the traditional drugs, which favour the concept of one-size-fits-all. This has ...  |  read more...
$1,699.00
Antibody Drug Conjugates Market, 2012-2023
5/31/2013 | published by: Roots Analysis
... of drug developers, with several large and small companies entering the market through collaboration and licensing agreements with technology providers. The ADC market is still in its infancy. So far, three ADCs have received market ...  |  read more...
$1,699.00
Alzheimer's Drugs Market, 2012 - 2017
5/10/2013 | published by: Roots Analysis
... the future. There is a huge unmet need in the market owing to lack of effective, disease-modifying drugs. Alzheimer’s treatment is a high risk, high reward market. Drugs currently available in the market have reached ...  |  read more...
$1,699.00
Neurostimulation Devices Market, 2012 - 2017
5/3/2013 | published by: Roots Analysis
... mainly focus on spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS) and sacral nerve stimulation (SNS). The market is still niche, with limited number of devices available in the market. The ...  |  read more...
$1,699.00
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!